Publicaciones en colaboración con investigadores/as de Universidad Complutense de Madrid (22)

2024

  1. How to use meropenem in pediatric patients undergoing CKRT? Integrated meropenem pharmacokinetic model for critically ill children

    Antimicrobial Agents and Chemotherapy, Vol. 68, Núm. 6

2023

  1. Editorial: Innovative pharmacometric approaches to inform drug development and clinical use

    Frontiers in Pharmacology

  2. Neglected Zoonotic Diseases: Advances in the Development of Cell-Penetrating and Antimicrobial Peptides against Leishmaniosis and Chagas Disease

    Pathogens, Vol. 12, Núm. 7

2022

  1. Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy

    Clinical Microbiology and Infection, Vol. 28, Núm. 9, pp. 1287.e9-1287.e15

2021

  1. Poloxamine/D-α-Tocopheryl polyethylene glycol succinate (TPGS) mixed micelles and gels: Morphology, loading capacity and skin drug permeability

    Journal of Molecular Liquids, Vol. 324

  2. Preclinical evaluation of the safety and immunological action of allogeneic ADSC-collagen scaffolds in the treatment of chronic ischemic cardiomyopathy

    Pharmaceutics, Vol. 13, Núm. 8

2020

  1. Finding the dose for ceftolozane-tazobactam in critically ill children with and without acute kidney injury

    Antibiotics, Vol. 9, Núm. 12, pp. 1-14

2018

  1. Plasmid-Templated Control of DNA–Cyclodextrin Nanoparticle Morphology through Molecular Vector Design for Effective Gene Delivery

    Chemistry - A European Journal, Vol. 24, Núm. 15, pp. 3825-3835

  2. Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH

    Clinical and Translational Oncology, Vol. 20, Núm. 4, pp. 443-447

  3. Proposal of the SEOM, SEAP and SEFH for the creation of a National Strategy for Precision Medicine in Cancer

    Revista Espanola de Patologia

2017

  1. Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: A position statement of SEOM, SEAP and SEFH

    Farmacia Hospitalaria, Vol. 41, Núm. 6, pp. 688-691

2016

  1. Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease

    Brain, Behavior, and Immunity, Vol. 57, pp. 94-105

  2. Trehalose-based Janus cyclooligosaccharides: The "click" synthesis and DNA-directed assembly into pH-sensitive transfectious nanoparticles

    Chemical Communications, Vol. 52, Núm. 66, pp. 10117-10120

2015

  1. Preliminary study of genotoxicity evaluation of orthodontic miniscrews on mucosa oral cells by the alkaline comet assay

    Toxicology Mechanisms and Methods, Vol. 25, Núm. 6, pp. 487-493

2013

  1. Maternal deprivation effects on brain plasticity and recognition memory in adolescent male and female rats

    Neuropharmacology, Vol. 68, pp. 223-231

2012

  1. Low efficacy of NcGRA7, NcSAG4, NcBSR4 and NcSRS9 formulated in poly-e{open}-caprolactone against Neospora caninum infection in mice

    Vaccine, Vol. 30, Núm. 33, pp. 4983-4992

2011

  1. Long Term Sex-Dependent Psychoneuroendocrine Effects of Maternal Deprivation and Juvenile Unpredictable Stress in Rats

    Journal of Neuroendocrinology, Vol. 23, Núm. 4, pp. 329-344

2010

  1. Neuroprotective and neurochemical properties of mint extracts

    Phytotherapy Research, Vol. 24, Núm. 6, pp. 869-874

2009

  1. Neuroprotective and neurological properties of melissa officinalis

    Neurochemical Research, Vol. 34, Núm. 11, pp. 1955-1961

  2. New 1-aryl-3-substituted propanol derivatives as antimalarial agents

    Molecules, Vol. 14, Núm. 10, pp. 4120-4135